Boya IVIG not checked

Azidus Brasil

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Intervention: Biological: Boya IVIG Boya IVIG is a 5% human immunoglobulin for intravenous administration”In the company’s words, NCT06150833 on ClinicalTrials.gov
Tested for
Primary Immunodeficiency Disease
Main trialPhase 3
“The goal of this phase 3, open-label, single-group clinical trial is to assess the efficacy of Boya IVIG in maintaining the mean number of serious bacterial infections to less than one per year in participants with primary immunodeficiency (PYD) due to common variable immunodeficiency (CVID), as defined by the European Immunodeficiency Society (ESCID) / Pan American Immunodeficiency Group (PAGID), or X-linked agammaglobulinemia (XLA), as defined by molecular genetic testing (ESCID/PAGID). The safety and pharmacokinetics (PK) of the investigational product will also be evaluated.…”In the company’s words, NCT06150833 on ClinicalTrials.gov
Other names
IVIG · BOYA

Other drugs for Primary Immunodeficiency Disease

All 29 drugs for Primary Immunodeficiency Disease

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting Sep 2028 IVIG Boya: Safety, Efficacy, and Pharmacokinetics
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Boya IVIG

Following is part of Solo: you see every change to Boya IVIG the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in